Delivery Order SPE2DB22D3016-SPE2DB25FBEA1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,064.07 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 4, 2025, with completion expected by August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the vendor's corporate...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $8,727.50 to AmerisourceBergen Drug Corp for the supply of Savella 100 mg tablets (60-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,092.15 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Savella 50 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA....
- The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 50 mg tablets in a quantity of 60 units. This contract, designated as a firm fixed price delivery order, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The award represents a non-competitive, non-set-aside transaction and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Savella 50 mg tablets (60 count) under a firm fixed-price contract. The contract, valued at $15,609.03, is scheduled for completion by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside restrictions, reflecting the contractor's capability to...
- The Defense Logistics Agency awarded a $2,111.57 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a neurological medication used in pain management. This competitive contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $4,806.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a medication primarily used for fibromyalgia treatment. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,309.08 firm fixed price delivery order is for the supply of Savella 50 mg tablets. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,853.58 fixed-price contract is for the delivery of SAVELLA 12.5 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEA1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Savella 50 mg tablets (60-count units) with a contract value of $26,478.90. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through competitive procurement with no set-aside designation. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Savella (milnacipran), a medication used in pain management and treatment of fibromyalgia, represents one of many pharmaceutical products the contractor delivers through its federal contract portfolio. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare programs worldwide. The company's demonstrated capability to meet federal procurement requirements through competitive procurement is evidenced by its substantial IDC with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 8/5/25 |